Drugs & TargetsFree FDA approves Tabrecta, first targeted therapy to treat metastatic NSCLC May 08, 2020Vol.46 No.19
Drugs & TargetsFree FDA approves daratumumab and hyaluronidase-fihj for multiple myeloma May 08, 2020Vol.46 No.19
Drugs & TargetsFree Caris Life Sciences submits two PMA applications to FDA for whole exome and whole transcriptome sequencing May 08, 2020Vol.46 No.19
Clinical RoundupFree Cancer patients without insurance or Medicaid don’t experience the same benefits of clinical trials May 08, 2020Vol.46 No.19
Clinical RoundupFree Libtayo shows clinically-meaningful and durable responses in second-line advanced basal cell carcinoma May 08, 2020Vol.46 No.19
Clinical RoundupFree New tumor sampling method significantly improves genetic testing for cancer treatment May 08, 2020Vol.46 No.19
FreeIn Brief Blumenthal named VP of Global Oncology Regulatory Affairs at Merck May 08, 2020Vol.46 No.19
FreeIn Brief Haura, Khushalani named clinical science research leaders at Moffitt May 08, 2020Vol.46 No.19
